Europe Needs Pharmaceutical Innovation, Not Higher Prices Without Conditions
A decade of Beneluxa yielded 15 assessments and three reimbursement deals, but no proof of added value.
Author profile
Jaume Puig-Junoy
Jaume Puig-Junoy is a health economist and Distinguished Professor at UPF Barcelona School of Management, where he directs the master's programmes in health economics and pharmacoeconomics. He is Vice-Chair of the Advisory Committee for the Financing of Pharmaceutical Benefits (CAPF) at Spain's health ministry and author of The Rise of Geopolitics in Health Policy (2026).